MOODY’S-ESG-SOLUTIONS
26.4.2022 11:19:04 CEST | Business Wire | Press release
Moody’s today launched Moody’s ESG360™, an easy-to-use platform that provides portfolio managers with ESG analyst-verified scores and modelled ESG and climate intelligence on private and public companies to bring clarity and confidence to investment decisions on environmental, social and governance (ESG) issues.
“To understand the short- and long-term impact of ESG and climate exposures, market participants need a holistic and reliable view of risks and opportunities,” said Andrea Blackman, Managing Director – Global Head of Moody’s ESG Solutions. “The launch of Moody’s ESG360™ demonstrates our commitment to providing comprehensive coverage to help portfolio managers make sustainable decisions with confidence. Coverage is much more than just a number; it’s a commitment to providing granular and clearly defined data, scores, and assessments – all delivered through platforms that meet customer needs.”
Moody’s ESG360™ allows portfolio managers to identify ESG leaders and laggards across themes, sectors, and regions, monitor and report on portfolio level performance across a broad range of research lines, and analyze key risk metrics at both the portfolio and entity level. All data points will be clearly labeled with their relevance to industry standards and traceable to their source.
At launch, Moody’s ESG360™ provides access to Moody’s physical and transition climate risk data sets across a recently expanded universe of 10,000 companies globally. In the coming months, the platform will be further enhanced with Moody’s ESG insights, including coverage of 300 million public and private companies through a combination of modelled and ESG analyst-verified scores.
Driven by a double materiality approach that accounts for both financial and stakeholder impacts, Moody’s ESG data, scores, and assessments provide a comprehensive view of the ESG performance of companies – including small and medium-sized enterprises (SMEs). This enables a unique assessment of how companies can create sustainable value for the environment, society, and stakeholders, as well as how companies are positioned to manage their exposure and response to ESG risks and opportunities.
Alongside Moody’s ESG360™, Moody’s recently launched a corporate engagement platform, Moody’s ESG360™ Connect, which enables corporates to easily connect with Moody’s regarding their sustainability disclosures and ensure accurate representation of their ESG data, ultimately expanding the data coverage that feeds into Moody’s ESG solutions.
To learn more about Moody’s ESG360™ or get a demo, visit: http://www.moodys.com/moodys-esg360 .
Sustainability is at the core of Moody's business, building better business, better lives and better solutions to create long-term value for society, the environment and the economy. For more information on Moody’s sustainability commitments, visit: https://about.moodys.io/sustainability
ABOUT MOODY’S ESG SOLUTIONS
Moody’s ESG Solutions is a business unit of Moody’s Corporation serving the growing global demand for ESG and climate insights. The group leverages data and expertise across ESG, climate risk, and sustainable finance, and aligns with Moody's Investors Service and Moody's Analytics to deliver a comprehensive, integrated suite of ESG and climate risk solutions including ESG scores, analytics, Sustainability Ratings and Sustainable Finance Reviewer/certifier services.
For more information visit, Moody’s ESG hub at www.moodys.com/esg .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220426005612/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 202619.2.2026 08:50:00 CET | Press release
Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for a poster presentation at the American Association for Cancer Research Immuno-Oncology (AACRIO) annual conference (February 18-21, 2026), in Los Angeles. The poster showcases new preclinical data and early clinical insights from the company's lead candidate, STC-1010, supporting it as a promising therapeutic option for MSS, immune-cold colorectal cancer (CRC)—a major unmet clinical need. In a syngeneic CT26 model, murine STC-1010 significantly inhibits tumor growth and extends survival by 40%. New mechanistic datas reveal expansion of CD4⁺ and CD8⁺ T cells in draining lymph nodes alongside a significant humoral response compared to control, demonstrating coordinated cellular and humoral immune activation in vivo. Other findings show that dendritic cells efficiently capture STC-1010, leading to their activation as demonstrated by transcripto
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer19.2.2026 08:30:00 CET | Press release
Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-DM1 If approved, Daiichi Sankyo and AstraZeneca’s ENHERTU has the potential to become a new standard of care in this early breast cancer setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) as a monotherapy for adult patients with HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committ
NHOA Energy Advances Delivery of the 51 MWh Broni Battery for Neoen in Italy19.2.2026 08:00:00 CET | Press release
The project confirms NHOA Energy’s long-term commitment to the Italian market NHOA Energy, global provider of utility-scale energy storage systems, is advancing the construction of the Broni Battery, a 10 MW/51 MWh project located in Broni (Pavia), Italy, executed for Neoen, one of the world’s leading independent producers of renewable energy. Civil works at the site are currently underway and advancing on schedule, with commissioning activities planned to start in late spring 2026. Once operational, the Broni Battery will provide essential flexibility services to the Italian electricity system, supporting grid stability and reliability as renewable energy penetration continues to increase. The project represents Neoen’s first battery storage asset in Italy and marks a strategic step in the company’s expansion, as it continues to grow its battery storage portfolio in key markets worldwide to support power system flexibility. The Broni Battery further strengthens NHOA Energy’s long-term
Compass Pathways Announces Pricing of $150 Million Public Offering19.2.2026 02:18:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 1,250,000 ADSs at a public offering price of $7.9999 per pre-funded warrant. In addition, Compass Pathways has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 ADSs at the public offering price, less the underwriting discounts and commissions. All of the securities are to be sold by Compass Pathways. The offering is expected to close on or about February 20, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to Compass Pathways from the offering, before deducting underwriting discounts and commissions and other est
Andersen Consulting udvider sine kompetencer inden for ledelsesrekruttering med Lansdowne Executive Search18.2.2026 17:08:00 CET | Pressemeddelelse
Andersen Consulting styrker sin humancapital-praksis gennem en samarbejdsaftale med Lansdowne Executive Search, der er en Dublin-baseret virksomhed med speciale i lederrekruttering, midlertidige ledelser og bestyrelsesudnævnelser. Lansdowne Executive Search er en irisk-ejet virksomhed, der blev grundlagt i 2015, og som tilbyder C-level-ledelsesekruttering, deltidsledere og bestyrelsesplaceringer. Som en partnerdrevet boutique-virksomhed er Lansdowne kendt for, at seniorledelsen er tæt involveret i alle kundeprojekter. Virksomheden hjælper kunder med at navigere i komplekse ledelsesovergange og vækststrategier på tværs af en bred vifte af sektorer, herunder finans, byggeindustrien, nonprofit, landbrug, videregående uddannelse, den offentlige sektor samt teknologi, medier og telekommunikation. "God ledelse er afhænger af situationen, og det kræver forståelse af langt mere end blot et CV," sagde Tom Keane, der er partner hos Lansdowne Executive Search. "Samarbejdet med Andersen Consulting
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
